Roswell Park Research Suggests New Strategy for Unleashing Cancer-Fighting Power of P53 Gene
December 12, 2017
December 12, 2017
BUFFALO, New York, Dec. 12 -- The Roswell Park Cancer Institute issued the following news release:
Tumor protein p53 is one of the most critical determinants of the fate of cancer cells, as it can determine whether a cell lives or dies in response to stress. In a new study published today in the journal Nature Communications, a research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute reports their discovery of a major mechanism by which cel . . .
Tumor protein p53 is one of the most critical determinants of the fate of cancer cells, as it can determine whether a cell lives or dies in response to stress. In a new study published today in the journal Nature Communications, a research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute reports their discovery of a major mechanism by which cel . . .